Clinical Trial Update: Levonorgestrel-Releasing Intrauterine System in Treating Patients With Complex Atypical Hyperplasia or Grade I Endometrial Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the levonorgestrel-releasing intrauterine system for complex atypical endometrial hyperplasia or early-stage endometrial cancer; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Endometrial Hyperplasia with Atypical Cells

Drugs mentioned

• Levonorgestrel-Releasing Intrauterine System (levonorgestrel-releasing intrauterine system)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Atypical Endometrial Hyperplasia, Stage I Uterine Corpus Cancer AJCC v7 | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2022-04-28